|
Goldman Has $13 Target On DR Horton (DHI)
Benzinga Goldman Sachs has a Buy rating on DR Horton, Inc. (NYSE: DHI) and a $13 price target. In a note to clients, Goldman writes, "The potential … Critical Movement for DR Horton (DHI)Market Intellisearch |
Random Pages
- New-Home Sales Rise 6.6 Percent in September - National Association of Home Builders (press release)
- Kankakee County: Kinzinger says home building key to economy - Kankakee Daily Journal
- Home prices, inventory still falling; KB Home, DR Horton Homes score highest - Inside Tucson Business
- Mortgage interest deduction has broad support among all voters - The Hill (blog)
- Pulte @ Year Lows - TradersHuddle.com
- Report Illustrates Economic Revival - Wall Street Journal
- Hernando County home builders showcase green innovations - Tampabay.com
- Dec. housing starts stronger in Pima, led by DR Horton - Arizona Daily Star
- Instant View: July housing starts rise less than expected - Reuters
- Next Wk/US: CPI/PPI/Exp Prices; Philly Fed; IP/Cap Ute;TICS - Market News International
-